Allient Inc

ALNT is in a Stage 4 decline, with a clear lower-high/lower-low sequence under bearish EMA control and distribution volume confirming sustained selling pressure. The medium-term bias remains bearish, but short-term timing is unfavorable as price has been rejected at declining EMAs and is now pulling back toward support. We will trim on rallies into the 9/21/50 EMA zone for rejection setups.

• ↑Orders up 15% YoY; backlog $251M implies strong demand
• ↑Q1 revenue $138.9M (+5% YoY); book-to-bill 1.14x signals growth
• ↓P/E at 62.8x well above peers, suggesting overvaluation